CLINICAL_TRIALS
trial_result
· 2019-12-18
Clinical Trial Update: Avelumab in Previously Untreated Patients With Epithelial Ovarian Cancer (JAVELIN OVARIAN 100) [Phase 3]
Summary
Phase 3 trial of avelumab in previously untreated epithelial ovarian cancer was terminated; results posted in 2019.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Ovarian Cancer | Phase 3 | Status: TERMINATED | Results posted: 2019-12-18